Andy Cope Professor Andrew Cope Academics Supervisors Professor of Rheumatology Head of the Centre for Rheumatic Diseases. Research subject areas Immunology Contact details andrew.cope@kcl.ac.uk
RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients The RA-MAP Consortium, Dec 2022, In: Scientific Data. 9, 1, 196. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1038/s41597-022-01264-y Management of gout following 2016/2017 European (EULAR) and British (BSR) guidelines: An interrupted time-series analysis in the United Kingdom Russell, M. D., Rutherford, A. I., Ellis, B., Norton, S., Douiri, A., Gulliford, M. C., Cope, A. P. & Galloway, J. B., Jul 2022, In: The Lancet Regional Health - Europe. 18, p. 100416 100416. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1016/j.lanepe.2022.100416 Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming Cooles, F. A. H., Tarn, J., Lendrem, D. W., Naamane, N., Lin, C. M. A., Millar, B., Maney, N. J., Anderson, A. E., Thalayasingam, N., Diboll, J., Bondet, V., Duffy, D., Barnes, M. R., Smith, G. R., Ng, S., Watson, D., Henkin, R., Cope, A. P., Reynard, L. N., Pratt, A. G. & 1 others, Isaacs, J. D., 9 Jun 2022, In: Annals of the rheumatic diseases. heartjnl-2022-222370. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1136/annrheumdis-2022-222370 Regulatory B cell repertoire defects predispose lung cancer patients to immune-related toxicity following checkpoint blockade Patel, A. J., Willsmore, Z. N., Khan, N., Richter, A., Naidu, B., Drayson, M. T., Papa, S., Cope, A., Karagiannis, S. N., Perucha, E. & Middleton, G. W., 7 Jun 2022, In: Nature Communications. 13, 1, p. 3148 3148. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1038/s41467-022-30863-x Levelling the playing field of RMD research across Europe to address patients' needs: the emerging EULAR Research Centre Reuter, K., Haupt, C., Molto, A., Cope, A., van Vollenhoven, R. F., Elewaut, D., Lories, R. & McInnes, I. B., 1 Jun 2022, In: RMD Open. 8, 2 Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1136/rmdopen-2022-002456 The impact of COVID-19 on clinical care, self-management and mental health of patients with inflammatory arthritis Sweeney, M., Carpenter, L., de Souza, S., Chaplin, H., Tung, H., Caton, E., Galloway, J., Cope, A., Yates, M., Nikiphorou, E. & Norton, S., 1 Jan 2022, In: Rheumatology Advances in Practice. 6, 1, p. rkab095 rkab095. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1093/rap/rkab095 Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study Mahil, S. K., Bechman, K., Raharja, A., Domingo-Vila, C., Baudry, D., Brown, M. A., Cope, A. P., Dasandi, T., Graham, C., Khan, H., Lechmere, T., Malim, M. H., Meynell, F., Pollock, E., Sychowska, K., Barker, J. N., Norton, S., Galloway, J. B., Doores, K. J., Tree, T. & 1 others, Smith, C. H., Jan 2022, In: The Lancet Rheumatology. 4, 1, p. e42-e52 Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1016/S2665-9913(21)00333-7 The citrullinated/native index of autoantibodies against hnRNP-DL predicts an individual “window of treatment success” in RA patients Marklein, B., Jenning, M., Konthur, Z., Häupl, T., Welzel, F., Nonhoff, U., Krobitsch, S., Mulder, D. M., Koenders, M. I., Joshua, V., Cope, A. P., Shlomchik, M. J., Anders, H. J., Burmester, G. R., Hensvold, A., Catrina, A. I., Rönnelid, J., Steiner, G. & Skriner, K., Dec 2021, In: Arthritis Research and Therapy. 23, 1, 239. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1186/s13075-021-02603-x A systematic review and network meta-analysis of the safety of early interventional treatments in rheumatoid arthritis Adas, M. A., Allen, V. B., Yates, M., Bechman, K., Clarke, B. D., Russell, M. D., Rutherford, A. I., Cope, A. P., Norton, S. & Galloway, J. B., 1 Oct 2021, In: Rheumatology. 60, 10, p. 4450-4462 13 p. Research output: Contribution to journal › Review article › peer-review. DOIs: https://doi.org/10.1093/rheumatology/keab429 EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis Mankia, K., Siddle, H. J., Kerschbaumer, A., Alpizar Rodriguez, D., Catrina, A. I., Cañete, J. D., Cope, A. P., Daien, C. I., Deane, K. D., El Gabalawy, H., Finckh, A., Holers, V. M., Koloumas, M., Ometto, F., Raza, K., Zabalan, C., Van Der Helm-Van Mil, A., Van Schaardenburg, D., Aletaha, D. & Emery, P., 1 Oct 2021, In: Annals of the rheumatic diseases. 80, 10, p. 1286-1298 13 p. Research output: Contribution to journal › Review article › peer-review. DOIs: https://doi.org/10.1136/annrheumdis-2021-220884 View all publications
18 May 2020 National trial launched to find Covid-19 treatment A new trial to prevent organ failure and death in Covid-19 patients is being launched and led by…